Filtros de búsqueda

Lista de obras de Jose R Arribas

96 week results from the MONET trial: a randomized comparison of darunavir/ritonavir with versus without nucleoside analogues, for patients with HIV RNA <50 copies/mL at baseline

article

96-Week results of abacavir/lamivudine versus tenofovir/emtricitabine, plus efavirenz, in antiretroviral-naive, HIV-1-infected adults: ASSERT study

artículo científico publicado en 2013

A 96-week comparison of lopinavir-ritonavir combination therapy followed by lopinavir-ritonavir monotherapy versus efavirenz combination therapy.

artículo científico publicado en 2008

A benchmark for management of drug resistant HIV

article

A clinical-parasitological monotherapy cure in the treatment of experimental infection by a highly virulent strain ofToxoplasma gondii

artículo científico publicado en 1996

A comparative study of neurocognitively impaired patients receiving protease inhibitor monotherapy or triple-drug antiretroviral therapy.

artículo científico publicado en 2014

A new murine model of severe acute toxoplasmia encephalitis

artículo científico publicado en 1995

A prospective cohort study of neurocognitive function in aviremic HIV-infected patients treated with 1 or 3 antiretrovirals.

artículo científico publicado en 2014

A simplification trial switching from nucleoside reverse transcriptase inhibitors to once-daily fixed-dose abacavir/lamivudine or tenofovir/emtricitabine in HIV-1-infected patients with virological suppression.

artículo científico publicado en 2009

Abnormalities in the bone mineral metabolism in HIV-infected patients

artículo científico publicado en 2005

Acute hepatitis in HIV-infected patients during ritonavir treatment

article

Advances in antiretroviral therapy

Advances in the diagnosis and treatment of infections caused by herpesvirus and JC virus

artículo científico publicado en 1998

Amphotericin B lipid complex versus no treatment in the secondary prophylaxis of visceral leishmaniasis in HIV-infected patients

artículo científico publicado en 2004

Analysis of costs and cost-effectiveness of preferred GESIDA/National AIDS Plan regimens for initial antiretroviral therapy in human immunodeficiency virus infected adult patients in 2013

artículo científico publicado en 2013

Analysis of drug resistance during HIV RNA viraemia in the MONET trial of darunavir/ritonavir monotherapy

article

Analysis of major and minor IAS-USA PI mutations in the MONET trial of darunavir/ritonavir monotherapy versus DRV/r + 2NRTIs.

artículo científico publicado en 2010

Angioedema and transient acquired C1 inhibitor functional deficiency in HIV infection: case report

article

Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditions

artículo científico publicado en 2014

Antiretroviral rounds. Is that "one pill" treatment enough?

artículo científico publicado en 2008

Análisis de costes y de coste/eficacia de las pautas preferentes de GESIDA/Plan Nacional sobre el Sida en 2012 para el tratamiento antirretroviral inicial en adultos infectados por el virus de la inmunodeficiencia humana (VIH)

Análisis farmacoeconómico de una estrategia de mantenimiento con lopinavir/ritonavir como monoterapia en pacientes con infección por el VIH

artículo científico publicado en 2006

Assessment of second-line antiretroviral regimens for HIV therapy in Africa

artículo científico publicado en 2014

Benefit of switching from a protease inhibitor (PI) to nevirapine in PI-experienced patients suffering acquired HIV-related lipodystrophy syndrome (AHL): interim analysis at 3 months of follow-up.

artículo científico publicado en 1999

Boosted protease inhibitor monotherapy in HIV-infected adults: outputs from a pan-European expert panel meeting

artículo científico publicado en 2013

Cartas al editor

artículo científico publicado en 2006

Causes and consequences of incomplete HIV RNA suppression in clinical trials

artículo científico publicado en 2009

Cerebral volumes, neuronal integrity and brain inflammation measured by MRI in patients receiving PI monotherapy or triple therapy

artículo científico publicado en 2014

Changes in lipid levels after 48 weeks of dual versus triple therapy observed in the GARDEL study

artículo científico publicado en 2014

Chorea during treatment with pegylated interferon and ribavirin in HIV-HCV coinfected patient

artículo científico publicado en 2009

Clinical benefit of lapatinib-based therapy in patients with human epidermal growth factor receptor 2-positive breast tumors coexpressing the truncated p95HER2 receptor.

artículo científico publicado en 2010

Clinical implications of fixed-dose coformulations of antiretrovirals on the outcome of HIV-1 therapy.

artículo científico publicado en 2011

Clinical, virologic, and immunologic response to efavirenz-or protease inhibitor-based highly active antiretroviral therapy in a cohort of antiretroviral-naive patients with advanced HIV infection (EfaVIP 2 study).

artículo científico publicado en 2004

Comparison between sequence analysis and a line probe assay for testing genotypic resistance of human immunodeficiency virus type 1 to antiretroviral drugs.

artículo científico publicado en 2005

Comparison of NNRTIs in antiretroviral-naïve patients.

artículo científico publicado en 2001

Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study

artículo científico publicado en 2010

Comparison of transient elastography and liver biopsy for the assessment of liver fibrosis in HIV/hepatitis C virus-coinfected patients and correlation with noninvasive serum markers

artículo científico publicado en 2009

Concomitant use of an active boosted protease inhibitor with enfuvirtide in treatment-experienced, HIV-infected individuals: recent data and consensus recommendations

artículo científico publicado en 2006

Consensus conference on chronic viral hepatitis and HIV infection: updated Spanish recommendations.

artículo científico publicado en 2004

Consensus document on the management of renal disease in HIV-infected patients.

artículo científico publicado en 2014

Constitutive HER2 signaling promotes breast cancer metastasis through cellular senescence.

artículo científico publicado en 2013

Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons

artículo científico publicado en 2013

Correlation between blood telomere length and CD4+ CD8+ T-cell subsets changes 96 weeks after initiation of antiretroviral therapy in HIV-1-positive individuals

artículo científico publicado en 2020

Cost-efficacy analysis of the MONET trial using Spanish antiretroviral drug prices

article

Cost/efficacy analysis of preferred Spanish AIDS study group regimens and the dual therapy with LPV/r+3TC for initial ART in HIV infected adults

artículo científico publicado en 2014

Costs and cost effectiveness analysis of preferred GESIDA regimens for initial antiretroviral therapy

artículo científico publicado en 2011

Cytomegalovirus encephalitis

artículo científico publicado en 1996

Demyelinating disease in human immunodeficiency virus-infected patients without severe immunodepression

artículo científico publicado en 2010

Dermatomyositis, Sjögren's syndrome and vasculitis: an infrequent overlapping connective disease

artículo científico publicado en 1992

Detection and quantification of the K103N mutation in HIV reverse transcriptase by pyrosequencing

artículo científico publicado en 2011

Detection of Epstein-Barr virus DNA in cerebrospinal fluid for diagnosis of AIDS-related central nervous system lymphoma

artículo científico publicado en 1995

Diarrea y pérdida de peso en varón con viaje reciente a Guatemala

artículo científico publicado en 2002

Discontinuation of Primary and SecondaryToxoplasma gondiiProphylaxis Is Safe in HIV‐Infected Patients after Immunological Restoration with Highly Active Antiretroviral Therapy: Results of an Open, Randomized, Multicenter Clinical Trial

article

Discontinuation of Secondary Prophylaxis in Patients with Cytomegalovirus Retinitis Who Have Responded to Highly Active Antiretroviral Therapy

artículo científico publicado en 2001

Drug resistance in patients experiencing early virological failure under a triple combination including indinavir

artículo científico publicado en 2001

Drugs in traditional drug classes (nucleoside reverse transcriptase inhibitor/nonnucleoside reverse transcriptase inhibitor/protease inhibitors) with activity against drug-resistant virus (tipranavir, darunavir, etravirine).

artículo científico publicado en 2009

Dual therapy with lopinavir and ritonavir plus lamivudine versus triple therapy with lopinavir and ritonavir plus two nucleoside reverse transcriptase inhibitors in antiretroviral-therapy-naive adults with HIV-1 infection: 48 week results of the ran

artículo científico publicado en 2014

Dynamics of cellular HIV-1 DNA levels over 144 weeks of darunavir/ritonavir monotherapy versus triple therapy in the MONET trial

artículo científico publicado en 2013

Early versus deferred antiretroviral therapy for HIV

article

Early virologic rebound in a pilot trial of ritonavir-boosted atanazavir as maintenance monotherapy

artículo científico publicado en 2007

Efavirenz: enhancing the gold standard.

artículo científico publicado en 2003

Effectiveness of protease inhibitor monotherapy versus combination antiretroviral maintenance therapy: a meta-analysis

artículo científico publicado en 2011

Efficacy of PI monotherapy versus triple therapy for 1964 patients in 10 randomised trials

artículo científico publicado en 2014

El papel de las combinaciones de antirretrovirales a dosis fijas en el tratamiento de la infección por VIH-1

Elevation of viral load by PCR and use of plasma preparation tubes for quantification of human immunodeficiency virus type 1.

artículo científico publicado en 2007

Epidemiological trends of HIV infection in Spain: preventative plans have to be oriented to new target populations (Spanish VACH Cohort).

artículo científico publicado en 2002

Estudio longitudinal de adherencia, satisfacción y efectividad del tratamiento antirretroviral administrado una vez al día, frente a dos veces al día, en una cohorte española de infectados por el VIH (estudio CUVA: cualquiera una vez al día)

artículo científico publicado en 2008

Etiology of hospital-acquired infections in Spanish hospitals (EPINE, 1990-1999)

artículo científico publicado en 2002

Evaluation of the carbohydrate metabolism in the drug addict

artículo científico publicado en 1989

Evidence of hepatitis C virus antibodies in the cryoprecipitate of patients with mixed cryoglobulinemia

artículo científico publicado en 1994

Evolution of protease inhibitor resistance in HIV-1-infected patients failing protease inhibitor monotherapy as second-line therapy in low-income countries: an observational analysis within the EARNEST randomised trial

article

Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2014).

artículo científico

Executive summary of the consensus document on the management of renal disease in HIV-infected patients.

artículo científico publicado en 2014

Executive summary of the recommendations on the evaluation and management of renal disease in human immunodeficiency virus-infected patients

artículo científico publicado en 2014

FLAMINGO: how much rosier can antiretroviral therapy get?

artículo científico publicado en 2014

Facial emotional processing deficits in long-term HIV-suppressed patients

artículo científico publicado en 2014

Factors associated with hepatic steatosis in human immunodeficiency virus and hepatits C virus coinfected patients

artículo científico publicado en 2009

Factors associated with treatment modification during the first year of contemporary HAART.

artículo científico publicado en 2010

Gut regulatory peptides and pancreatic beta-cell response to nutritional stimuli in the elderly.

artículo científico publicado en 1990

HAART is associated with lower hepatic necroinflammatory activity in HIV-hepatitis C virus-coinfected patients with CD4 cell count of more than 350 cells/microl at the time of liver biopsy

artículo científico publicado en 2009

High effectiveness of efavirenz-based highly active antiretroviral therapy in HIV-1-infected patients with fewer than 100 CD4 cells/microl and opportunistic diseases: the EfaVIP Study (Efavirenz in Very Immunosuppressed Patients).

artículo científico publicado en 2002

Hipertensión arterial, infección por el virus de la inmunodeficiencia humana y tratamiento antirretrovírico de gran actividad

Hypertension and isolated office hypertension in HIV-infected patients determined by ambulatory blood pressure monitoring: prevalence and risk factors

artículo científico publicado en 2011

Immune reconstitution in severely immunosuppressed antiretroviral-naive HIV type 1-infected patients using a nonnucleoside reverse transcriptase inhibitor-based or a boosted protease inhibitor-based antiretroviral regimen: three-year results (The Ad

artículo científico publicado en 2010

Immunological predictors of CD4+ T cell decline in antiretroviral treatment interruptions.

artículo científico publicado en 2008

Impact of protease inhibitor therapy on HIV-related oropharyngeal candidiasis

article

Imported Plasmodium falciparum malaria in HIV-infected patients: a report of two cases

artículo científico publicado en 2012

Improvement in vitamin D deficiency following antiretroviral regime change: Results from the MONET trial

artículo científico

Inappropriate claim of ‘failure of ritonavir-boosted lopinavir monotherapy in HIV’ in the Monotherapy Switzerland/Thailand (MOST) trial

article

Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy: A Cohort Study

artículo científico publicado en 2020

Incidence of hepatocellular carcinoma in HIV-infected patients with cirrhosis: a prospective study

artículo científico publicado en 2014

Incorrect attribution of cerebrospinal fluid HIV-1 virological escape and lymphocytic meningitis to lopinavir/ritonavir monotherapy.

artículo científico publicado en 2010

Inflammatory, procoagulant markers and HIV residual viremia in patients receiving protease inhibitor monotherapy or triple drug therapy: a cross-sectional study

artículo científico publicado en 2014

Influencia del hospital de día en los requerimientos de ingreso hospitalario de los pacientes con sida

scientific article published on 01 May 2000

Influenza A pandemic (H1N1) 2009 virus and HIV.

artículo científico publicado en 2010

Influenza-like illness in pregnant women during summertime: clinical, epidemiological and microbiological features.

artículo científico publicado en 2011

Initial antiretroviral therapy: The dilemmas ahead

Interferon plus ribavirin in HIV-infected patients with chronic hepatitis C.

artículo científico publicado en 1999

Interleukin-6 and C-reactive protein levels after 3 years of treatment with darunavir/ritonavir monotherapy or darunavir/ritonavir + two nucleoside reverse transcriptase inhibitors in the MONET trial

artículo científico publicado en 2012

Is etravirine and two nucleosides an option for HIV with an isolated K103N mutation?

artículo científico publicado en 2013

Level of cytomegalovirus (CMV) DNA in cerebrospinal fluid of subjects with AIDS and CMV infection of the central nervous system

artículo científico publicado en 1995

Lipid and apoprotein profile in HIV-1-infected patients after CD4-guided treatment interruption

artículo científico publicado en 2008

Lipid disorders in antiretroviral-naive patients treated with lopinavir/ritonavir-based HAART: frequency, characterization and risk factors

artículo científico publicado en 2005

Lipid levels and changes in body fat distribution in treatment-naive, HIV-1-Infected adults treated with rilpivirine or Efavirenz for 96 weeks in the ECHO and THRIVE trials

artículo científico publicado en 2014

Long-term (4 years) efficacy of lopinavir/ritonavir monotherapy for maintenance of HIV suppression.

artículo científico publicado en 2008

Long-term control of HIV replication with dolutegravir and pegylated interferon alpha-2a in an HIV-infected patient with sixtuple-class resistance.

artículo científico publicado en 2014

Long-term outcomes of switching to fixed-dose abacavir/lamivudine (ABC/3TC) or tenofovir/emtricitabine (TDF/FTC): 3-year results of the BICOMBO study.

artículo científico publicado en 2010

Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and 2 nucleosides for maintenance therapy of HIV: 96-week analysis.

artículo científico publicado en 2009

Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and two nucleosides for maintenance therapy of HIV.

artículo científico publicado en 2008

Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection.

artículo científico publicado en 2002

Lopinavir/ritonavir as single-drug therapy for maintenance of HIV-1 viral suppression: 48-week results of a randomized, controlled, open-label, proof-of-concept pilot clinical trial (OK Study).

artículo científico publicado en 2005

Low-level viraemia during treatment with darunavir/r monotherapy versus DRV/r + 2NRTIs in the MONET trial

artículo científico publicado en 2010

Magnetic resonance brain imaging lacks sensitivity for AIDS associated cytomegalovirus encephalitis.

artículo científico publicado en 1996

Major blinding complication of acquired immune deficiency syndrome (AIDS)

artículo científico publicado en 1997

Molecular characterization of five patients with homocystinuria due to severe methylenetetrahydrofolate reductase deficiency.

artículo científico publicado en 2010

Naïve patients receiving TDF/FTC-EFV as 2 pills are more likely to modify regimen components than patients receiving a TDF/FTC/EFV single pill. ⬇️

artículo científico publicado en 2010

Neurocognitive impairment in patients treated with protease inhibitor monotherapy or triple drug antiretroviral therapy

artículo científico publicado en 2013

Neuropsychiatric adverse events with ritonavir-boosted darunavir monotherapy in HIV-infected individuals: a randomised prospective study

artículo científico publicado en 2010

No Evidence for Evolution of Protease Inhibitor Resistance from Standard Genotyping, After Three Years of Treatment with Darunavir/Ritonavir, With or Without Nucleoside Analogues

article

No difference in the rate of change in telomere length or telomerase activity in HIV-infected patients after three years of darunavir/ritonavir with and without nucleoside analogues in the MONET trial

artículo científico publicado en 2014

Non-occupational postexposure prophylaxis to human immunodeficiency virus: a two sided sword?

artículo científico publicado en 2000

Noninferiority and lopinavir/ritonavir monotherapy trials

artículo científico publicado en 2008

Obstetric and perinatal complications in HIV-infected women. Analysis of a cohort of 167 pregnancies between 1997 and 2003

article

Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trial

article

Parvovirus B19–Related Anemia in an HIV-Infected Patient: Rapid Control after Production of Neutralizing Antibodies during Highly Active Antiretroviral Therapy

article

Patrón epidemiológico de la infección por el VIH en 15 hospitales españoles: casos de nuevo diagnóstico incluidos en la cohorte VACH en 2001 y 2002

scientific article published on 01 April 2005

Pattern of neurocognitive function in patients receiving boosted protease inhibitor monotherapy: a detailed neuropsychological study

artículo científico publicado en 2014

Pegylated IFN-alpha2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients

artículo científico publicado en 2003

Pharmacokinetics of lopinavir/ritonavir in HIV/hepatitis C virus-coinfected subjects with hepatic impairment

artículo científico publicado en 2006

Phenotype or virtual phenotype for choosing antiretroviral therapy after failure: a prospective, randomized study.

artículo científico publicado en 2003

Pneumocystis jirovecii pneumonia in Spanish HIV-infected patients in the combined antiretroviral therapy era: prevalence of dihydropteroate synthase mutations and prognostic factors of mortality

artículo científico publicado en 2008

Predictors of long-term HIV RNA suppression on darunavir/ritonavir monotherapy in the MONET trial

artículo científico publicado en 2013

Prevalence of infection by carbapenem-resistant Acinetobacter baumannii in Spain (1999-2005)

artículo científico publicado en 2008

Prevalencia del virus de la inmunodeficiencia humana (VIH) subtipo 1 con tropismo R5 en pacientes infectados por el VIH-1 pretratados en España

article

Prevention of opportunistic infections in adult and adolescent patients with HIV infection. GESIDA/National AIDS Plan guidelines, 2004 [correction].

artículo científico publicado en 2004

Protease inhibitor monotherapy and the CNS: peace of mind?

artículo científico publicado en 2011

Protease inhibitor monotherapy.

artículo científico publicado en 2011

Protease inhibitor monotherapy: what is its role?

artículo científico

Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trial.

artículo científico publicado en 2011

Recomendaciones españolas sobre el uso adecuado de enfuvirtida

artículo científico publicado en 2007

Relación entre fibrosis hepática medida por elastografía transitoria y valores de linfocitos CD4+ en sangre periférica

scientific article published on 01 November 2008

Renal safety profile of STB in virologically suppressed subjects from two randomized phase 3b switch trials

artículo científico publicado en 2014

Restoration of T Cell Responses to Toxoplasma gondii after Successful Combined Antiretroviral Therapy in Patients with AIDS with Previous Toxoplasmic Encephalitis

article

Risk factors for loss of virological suppression in patients receiving lopinavir/ritonavir monotherapy for maintenance of HIV suppression.

artículo científico publicado en 2009

Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial

artículo científico publicado en 2014

Role of the Juxtamembrane Domains of the Transforming Growth Factor-α Precursor and the β-Amyloid Precursor Protein in Regulated Ectodomain Shedding

artículo científico publicado en 1997

Severe nucleoside-associated lactic acidosis in human immunodeficiency virus-infected patients: report of 12 cases and review of the literature

artículo científico publicado en 2002

Shedding of plasma membrane proteins.

artículo científico publicado en 2003

Simplification to Stribild vs continuation of RTV-boosted DRV with FTC and TDF in virologically suppressed HIV adults: a STRATEGY-PI subgroup analysis

artículo científico publicado en 2014

Simplification to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of ritonavir-boosted protease inhibitor with emtricitabine and tenofovir in adults with virologically suppressed HIV (STRATEGY-PI): 48 week res

artículo científico publicado en 2014

Single (B or C), dual (BC or BD) and triple (BCD) viral hepatitis in HIV-infected patients in Madrid, Spain

article

Single genome sequencing of HIV-1 gag and protease resistance mutations at virologic failure during the OK04 trial of simplified versus standard maintenance therapy

artículo científico publicado en 2011

Smoking-related health risks among persons with HIV in the Strategies for Management of Antiretroviral Therapy clinical trial

article

Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in European HIV-infected patients with anti-HCV antibodies

artículo científico publicado en 2009

Switching from boosted PIs to dolutegravir decreases soluble CD14 and adiponectin in high cardiovascular risk people living with HIV

artículo científico publicado en 2021

Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV.

artículo científico publicado en 2006

Tenofovir Disoproxil Fumarate, Emtricitabine, and Efavirenz Versus Fixed-Dose Zidovudine/Lamivudine and Efavirenz in Antiretroviral-Naive Patients

article

Tenofovir disoproxil fumarate, emtricitabine, and efavirenz compared with zidovudine/lamivudine and efavirenz in treatment-naive patients: 144-week analysis

artículo científico publicado en 2008

The MONET trial: correlation between Hepatitis C coinfection and HIV RNA responses during darunavir/ritonavir monotherapy, for patients with HIV RNA <50 copies/mL at baseline

article

The MONET trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV RNA below 50 copies/ml

artículo científico publicado en 2010

The MONET trial: week 144 analysis of the efficacy of darunavir/ritonavir (DRV/r) monotherapy versus DRV/r plus two nucleoside reverse transcriptase inhibitors, for patients with viral load < 50 HIV-1 RNA copies/mL at baseline.

artículo científico publicado en 2012

The PROTEA trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV-1 RNA below 50 copies/mL

artículo científico publicado en 2014

The future of antiretroviral therapy: challenges and needs

artículo científico publicado en 2010

The level of persistent HIV viremia does not increase after successful simplification of maintenance therapy to lopinavir/ritonavir alone

article

The natural history of liver cirrhosis in HIV-hepatitis C virus-coinfected patients

artículo científico publicado en 2011

The rise and fall of triple nucleoside reverse transcriptase inhibitor (NRTI) regimens

artículo científico publicado en 2004

The state of PI monotherapy and NRTI-sparing therapy

artículo científico publicado en 2010

Three cases of early neurosyphilis in HIV patients

artículo científico publicado en 2006

Treatment of AIDS-associated prurigo nodularis with thalidomide

article

Treatment of Ebola virus disease.

artículo científico publicado en 2014

Treatment of advanced HIV infection

artículo científico publicado en 2003

Treatment of visceral leishmaniasis with intravenous pentamidine and oral fluconazole in an HIV-positive patient with chronic renal failure--a case report and brief review of the literature

artículo científico publicado en 2009

Tromboflebitis y neumonía en paciente VIH

scientific article published on 01 June 2006

Underpowered clinical trials of antiretroviral treatment

artículo científico publicado en 2002

Updating our understanding of pulmonary disease associated with HIV infection.

artículo científico publicado en 2012

Week 48 results from a randomized clinical trial of rilpivirine/emtricitabine/tenofovir disoproxil fumarate vs. efavirenz/emtricitabine/tenofovir disoproxil fumarate in treatment-naive HIV-1-infected adults

artículo científico publicado en 2014

Who will benefit from treatment against EGFR?

scientific article published on 01 May 2005

[Anti-phospholipid antibodies]

artículo científico publicado en 1988

[Association of hepatitis C virus and cryoglobulinemia]

scientific article published on 01 November 1992

[HIV-1 neuropathogenesis: therapeutic strategies against neuronal loss induced by gp120/Tat glycoprotein in the central nervous system]

scientific article published on 01 January 2011

[Importance of risk factors in the extension of pulmonary thromboembolism]

artículo científico publicado en 1990

[Prevalences of hepatitis virus coinfection and indications for chronic hepatitis C virus treatment and liver transplantation in Spanish HIV-infected patients. The GESIDA 29/02 and FIPSE 12185/01 Multicenter Study].

artículo científico publicado en 2005

[Role of the new molecules in antiretroviral therapy. Position of raltegravir].

artículo científico publicado en 2008

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda